US2018110788A1PendingUtilityA1

Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells

Assignee: HUTCHINSON FRED CANCER RESPriority: Aug 9, 2011Filed: May 25, 2017Published: Apr 26, 2018
Est. expiryAug 9, 2031(~5 yrs left)· nominal 20-yr term from priority
C12N 15/1137A61K 31/713A61K 31/404C12N 15/1135C12Y 207/11001A61K 31/65A61K 31/00C12N 2310/14
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using inhibitors of genes for inhibiting the growth and/or proliferation of MYC-driven tumor cells relative to normal cells.

Claims

exact text as granted — not AI-modified
1 . A method for inhibiting the growth and/or proliferation of an ovarian tumor cell having increased expression of a Myc transcription factor as compared to a non-tumor cell of the same cell type, comprising the step of contacting the tumor cell with at least one inhibitor that inhibits the gene product of a CRKRS gene. 
     
     
         2 . (canceled) 
     
     
         3 . The method of  claim 1 , wherein the tumor cell is contacted in vitro. 
     
     
         4 . The method of  claim 1 , wherein the tumor cell is contacted in vivo in a mammalian subject. 
     
     
         5 . The method of  claim 1 , wherein the inhibitor is a small molecule inhibitor that inhibits the function of the gene product. 
     
     
         6 .- 9 . (canceled) 
     
     
         10 . A method of treating a subject suffering from an ovarian tumor having increased expression of a Myc transcription factor as compared to a non-tumor cell of the same cell type, comprising administering to the subject an amount of a composition comprising an inhibitor that inhibits the gene product of a CRKRS gene and is effective to inhibit the growth and/or proliferation of the tumor cells. 
     
     
         11 . The method of  claim 10 , wherein the inhibitor is a small molecule inhibitor that inhibits the function of the gene product.

Join the waitlist — get patent alerts

Track US2018110788A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.